0001209191-23-044284.txt : 20230802
0001209191-23-044284.hdr.sgml : 20230802
20230802180010
ACCESSION NUMBER: 0001209191-23-044284
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230731
FILED AS OF DATE: 20230802
DATE AS OF CHANGE: 20230802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRYSKA DAVID W
CENTRAL INDEX KEY: 0001202335
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38052
FILM NUMBER: 231137326
MAIL ADDRESS:
STREET 1: 749 N MARY AVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Forte Biosciences, Inc.
CENTRAL INDEX KEY: 0001419041
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261243872
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3060 PEGASUS PARK DRIVE
STREET 2: BUILDING 6
CITY: DALLAS
STATE: TX
ZIP: 75247
BUSINESS PHONE: (310) 618-6994
MAIL ADDRESS:
STREET 1: 3060 PEGASUS PARK DRIVE
STREET 2: BUILDING 6
CITY: DALLAS
STATE: TX
ZIP: 75247
FORMER COMPANY:
FORMER CONFORMED NAME: Tocagen Inc
DATE OF NAME CHANGE: 20071120
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-07-31
0
0001419041
Forte Biosciences, Inc.
FBRX
0001202335
GRYSKA DAVID W
C/O FORTE BIOSCIENCES, INC.
3060 PEGASUS PARK DR., BUILDING 6
DALLAS
TX
75247
1
0
0
0
0
Common Stock
2023-07-31
4
A
0
148514
1.01
A
148514
D
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
2023-08-02